Business
PAOG Confirms CBD Pharmaceutical Partnership With New PURA Hemp Initiative
PAOG Confirms CBD Pharmaceutical Partnership With New PURA Hemp Initiative.
About this update from Pao Group, Inc.
[{"type":"text","content":"\n\n\n\nPAOG Confirms CBD Pharmaceutical Partnership With New PURA Hemp Initiative\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nPAOG Confirms CBD Pharmaceutical Partnership With New PURA Hemp Initiative\nPR Newswire\nSANDUSKY, Ohio, Nov. 12, 2020\n\n\n\nSANDUSKY, Ohio, Nov. 12, 2020 /PRNewswire/ -- PAO Group, Inc. (USOTC: PAOG) today confirmed a pharmaceutical and neurocritical extraction partnership with Puration, Inc. (USOTC: PURA).\nPURA has acquired a 72-acre property in Farmersville, Texas as the foundation of an innovative, hemp processing plant. PURA is building partnerships to participate in the project to include a pharmaceutical and neurocritical extraction partnership with PAOG.\nPURA has also established a co-packing partnership with Alkame Holdings, Inc. (USOTC: ALKM).  \nEarlier this week, PURA published a multimedia presentation on the new initiative in Texas:\nPURA Targets Hemp Consumer Advocates To Capture $26 Billion Market\nPAOG acquired a cannabis cultivation operation from PURA earlier this year in a transaction that includes issuing PAOG shares to PURA shareholders. The target distribution ratio calls for PURA shareholders receiving one share of PAOG for every one share of PURA owned.\nFor more information on PAO Group, visit www.paogroupinc.com\nSign up to receive the latest updates at www.purationinc.com.\nDisclaimer/Safe Harbor:\nThis news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this relea...